Company Search:
Advanced Search
Sponsored Links
Kalbe Farma Tbk PT Company Snapshot
Kalbe Farma Tbk PT operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kalbe Farma Tbk PT with three other pharmaceutical manufacturers in Asia: Cadila Healthcare Ltd of India (2015 sales of 86.51 billion Indian Rupees [US$1.32 billion] of which 100% was Pharmaceutical Products), Zhejiang Hisun Pharmaceutical, Ltd. of China (8.77 billion Chinese Renmimbi [US$1.27 billion] of which 64% was Drug/Medicine Sales), and Jiangsu Hengrui Medicine Co., Ltd. which is also based in China (9.32 billion Chinese Renmimbi [US$1.35 billion] of which 98% was Medicinal Manufacturing).

Sales Analysis. Kalbe Farma Tbk PT reported sales of 17.89 trillion Indonesian Rupiahs (US$1.34 billion) for the year ending December of 2015. This represents an increase of 3.0% versus 2014, when the company's sales were 17.37 trillion Indonesian Rupiahs. Sales at Kalbe Farma Tbk PT have increased during each of the previous five years (and since 2010, sales have increased a total of 75%). Sales of Nutritionals saw an increase that was more than double the company's growth rate: sales were up 11.6% in 2015, from 4.58 trillion Indonesian Rupiahs to 5.11 trillion Indonesian Rupiahs. Kalbe Farma Tbk PT also saw significant increases in sales in Consumer Health (up 4.9% to 3.07 trillion Indonesian Rupiahs) . Not all segments of Kalbe Farma Tbk PT experienced an increase in sales in 2015: sales of Distribution and Logistics fell 2.2% to 5.41 trillion Indonesian Rupiahs. Kalbe Farma Tbk PT also experienced decreases in sales in Prescription Pharmaceutical (down 0.8% to 4.29 trillion Indonesian Rupiahs) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kalbe Farma Tbk PT
  Stock Performance Chart for Kalbe Farma Tbk PT
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 1,505.00
(Figures in Indonesian Rupiahs)
1 Week -0.3%   13 Weeks 0.7%  
4 Weeks 4.5%   52 Weeks 16.2%  
Kalbe Farma Tbk PT Key Data:
  Ticker: KLBF Country: Indonesia
  Exchanges: JAK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 17,887,464,223,321
(Year Ending Jan 2016).
Employees: 12,611
  Currency: Indonesian Rupiahs Market Cap: 70,547,058,775,550
  Fiscal Yr Ends: December Shares Outstanding: 46,875,122,110
  Share Type: Ordinary Closely Held Shares: 26,539,630,885
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.